Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use programEvelien Kneppers, Henk M Lokhorst, Corien M Eeltink, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40Gustaaf W van Imhoff, Bronno van der Holt, Marius A Mackenzie, et al.Hemoglobin|March 11, 2004
A new Hb evanston allele [alpha14(A12)Trp --> Arg] found solely, and in the presence of common alpha-thalassemia deletions, in three independent Asian casesCornelis L Harteveld, Pierre W Wijermans, Juliette E L M de Ree, et al.Blood|April 13, 2006
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBruce D Cheson, Peter L Greenberg, John M Bennett, et al.Haematologica|November 8, 2011
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyMichael Lübbert, Björn H Rüter, Rainer Claus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.British Journal of Haematology|February 26, 2013
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myelomaPeter M Voorhees, Robert F Manges, Pieter Sonneveld, et al.Leukemia Research|August 4, 2004
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adultsSimon Daenen, Bronno van der Holt, Gregor E G Verhoef, et al.Haematologica|February 10, 2015
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology OncologyBouke P C Hazenberg, Alexandra Croockewit, Bronno van der Holt, et al.Annals of Hematology|September 25, 2015
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)Heiko Becker, Stefan Suciu, Björn Hans Rüter, et al.Pageof 5